Patent · US Active

Delivery methods and compositions for nuclease-mediated genome engineering

US10450585B2 · kind B2 · utility

5Cited by
51References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2016
Grant dateOct 22, 2019
Priority date
Expiry dateJul 13, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.